Stryker Reports Positive Results in Trevo Retriever System Clinical Trial

According to the company, study results show the device significantly improved revascularization over previous devices used in acute stroke care.

Today at the European Stroke Conference in Lisbon, Portugal, Stryker announced the results of the TREVO 2 clinical trial. The study met the primary effectiveness endpoint, with the Trevo Retriever achieving significantly better post-device revascularization than the Merci Retriever (86.4% in the Trevo Retriever arm compared to 60% in the Merci Retriever arm). The rates of functional independence at 90 days for patients treated with the Trevo Retriever were also better than for the Merci Retriever (40% mRS less than or equal to 2 compared to 21.8%).

No votes yet
Syndicate content